Do you have to increase your Mounjaro dose?

What the trial evidence actually says about higher doses

The SURMOUNT-1 study, published in the New England Journal of Medicine, randomised 2,539 adults with obesity over 72 weeks. At 15 mg, participants achieved an average body-weight reduction of around 20–21%. At 10 mg the average was closer to 19%. Both figures were substantially higher than at lower doses, which is where the assumption comes from that you must keep climbing.

That assumption is understandable. But the trial also showed that a meaningful proportion of participants lost clinically significant weight before they reached the top dose. If you are wondering whether you actually have to increase your Mounjaro dose, the data describes group averages, not a rule about what any individual must do.

Mounjaro (tirzepatide) is the only dual GIP and GLP-1 receptor agonist licensed in the UK for weight management. Its mechanism of acting on two gut-hormone pathways is one reason the dose-response curve is steeper than with single-agonist medicines, and understanding why prescribers encourage Mounjaro dose increases helps explain why titration is often recommended, but encouraging is different from mandating.

Reasons a prescriber might keep your dose where it is

There is a common misconception that stopping a dose increase means treatment has stalled. In practice, prescribers routinely hold doses for legitimate clinical reasons. Nausea, vomiting, and other gastrointestinal effects are most pronounced after starting or after each step up; if they have not settled, increasing the dose before they do often makes things worse, not better.

Similarly, if your weight loss is tracking well at 5 mg or 7.5 mg, your prescriber may see little clinical reason to expose you to higher-dose side-effect risk straight away. The NHS tirzepatide guidance makes clear that the schedule is a framework, and that individual response and tolerability shape how it is applied. Some people stay comfortably at an intermediate dose throughout their treatment course, that is not failure.

If you are curious about the cost implications of different doses, the Mounjaro price guide explains how private treatment is structured, which can be useful context when talking through options with your prescriber.

When titrating upward is the right call, and how the decision is made

A prescriber typically considers moving you up when: side effects at your current dose have settled over several weeks; weight loss has plateaued despite good adherence to dietary changes; and you are not at a dose that already represents your highest tolerated level. None of those criteria requires you to be at the maximum.

NICE's appraisal of tirzepatide (TA1026) notes that if less than 5% weight loss has been achieved after six months at the highest tolerated dose, continuing treatment should be reviewed. The phrase matters: "highest tolerated dose", not "maximum licensed dose". If 10 mg is causing persistent, unmanageable side effects, that is your highest tolerated dose, and your prescriber works from there.

At nume, every repeat order is reviewed by a GPhC-registered Independent Prescriber before it is dispensed. A real clinician looks at your progress, not a software prompt. If a dose increase is appropriate for you, the prescriber will say so; if holding steady is the right call, that is what they will recommend. You can read more about how timing a Mounjaro dose increase is assessed in clinical practice.

What to do if you have concerns about your current dose

If you are unsure whether your current dose is right, the right move is to raise it with your prescriber before your next pen arrives. Do not adjust timing or quantity based on information you have read online, including this page, dosing decisions belong in a clinical conversation.

Some patients ask about splitting or altering KwikPen doses, which is a separate question your prescriber can address. What matters is that any change, up or down, is made with clinical oversight. If you are not yet on Mounjaro and want to understand the full treatment picture, exploring weight-loss treatments at nume is the right starting point, our prescribers can assess which dose pathway suits your situation from the outset.